Elon Musk's Remarkable Endeavors: Neuralink to Conduct Human Trials for Brain-Machine Interface

#Consumer Electronics# Published : Sep 26, 2023

Elon Musk's Remarkable Endeavors: Neuralink to Conduct Human Trials for Brain-Machine Interface.

Elon Musk's prowess extends beyond the global success of Tesla, as he once again takes the spotlight in trending news. This time, Musk is embarking on an extraordinary mission through his company, Neuralink, which is set to conduct human trials—a development that could resemble a plotline from a large-scale science fiction movie.

Previously, Neuralink had conducted animal trials for brain-machine interface technology. Now, Neuralink has officially announced that it has obtained approval from an independent review committee to commence its first human trials, involving the implantation of devices into the brains of paralyzed patients. This six-year human trial will primarily focus on assessing the safety and effectiveness of Neuralink's wireless fully implanted brain-machine interface, enabling paralyzed patients to control external devices using their brains. Notably, Neuralink's clinical trials had previously received approval from the U.S. Food and Drug Administration (FDA).

Neuralink, founded by Elon Musk, has short-term objectives that include enabling paralyzed individuals to type via thought control. In the future, Neuralink aims to help paralyzed individuals regain the ability to walk and restore their vision.

What Is a Brain-Machine Interface?

A Brain-Machine Interface (BMI) or Brain-Computer Interface (BCI) refers to a direct connection established between the human or animal brain and external devices, facilitating the exchange of information between the brain and the devices.

A brain-machine interface represents a direct communication channel between the brain and external devices. Its signals originate from the central nervous system, operating independently of the peripheral nervous and muscular systems. BMIs can be employed to assist, enhance, or restore sensory-motor functions in the human body or augment human-machine interaction capabilities. For example, connecting a human brain to a computer allows individuals to manipulate machines effortlessly through thought, or connecting human brains to each other via computers enables non-verbal communication.

Moreover, with the development of artificial intelligence and machine learning, brain-machine interface technology has garnered increasing attention.

Brain-Machine Interface Companies

Several companies in the industry are actively researching and developing brain-machine interface technology.

  1. Neuralink: Founded by Elon Musk, CEO of Tesla, Neuralink is one of the most renowned companies in the field of brain-machine interfaces.

  2. Kernel: Established in 2016 by Bryan Johnson, Kernel is a brain-machine interface company.

  3. NeuroSky: A company specializing in the development of human brain interface technology.

  4. CTRL-labs: A startup company focused on the development of brain-machine interface technology.

  5. Emotiv: Researches headwear devices that allow control of games and applications through brainwave patterns.

READ ALSO

  • Compatible with ADS1258, 16-channel 24-bit SC1642 is used in medical biochemical detection systems Date: 26/09/2023

    A biochemical analyzer is a system that employs various electrochemical and optical techniques to analyze and detect biological samples. This system comprises an optical engine, sample movement/flow control, automated control and processing, power management, and environmental monitoring and control (temperature, pressure, humidity). To enhance efficiency, biochemical analyzers available in the market are highly automated.

  • Rockley Photonics completes trial of wearable blood pressure monitoring device Date: 26/09/2023

    Recently, Rockley Photonics, a developer of silicon photonics technology for healthcare applications, announced the results of trials using their wearable device to monitor blood pressure. These trials, approved by an Institutional Review Board (IRB), build upon preliminary pilot studies completed in 2022, marking progress in the commercialization of Rockley Photonics' first-generation Alpha device.

  • Application of ATA-4315 high-voltage power amplifier in high-frequency physical therapy instrument drive Date: 26/09/2023

    In modern society, with the pressures of life and work, coupled with unhealthy lifestyle habits, our bodies may inevitably encounter various health issues. As technology advances, we are witnessing the increasing application of multiple instruments and devices in clinical settings to assist medical professionals in treatment. One such device is the high-frequency physiotherapy machine.